Procter & Gamble May Be Looking Soon to Take Bids to Sell pharmaceutical unit

Everyone is probably more familiar with their products we buy at the grocery store with their consumer line of Head and Shoulders and Gillette , but they do also have a pharmaceutical division. They also have a patient assist program and more information can be found here on getting help for free drugs if you qualify.

Here are a few of the Proctor and Gamble drugs:

Actonel® (risedronate sodium tablets)
Actonel® with Calcium (risedronate sodium tablets with calcium carbonate)
Asacol® (mesalamine delayed release tablets)
Didronel® (etidronate disodium tablets)
Macrobid® (nitrofurantoin monohydrate/macrocrystals capsules)
Macrodantin® (nitrofurantoin macrocrystals capsules)

In a related story, P and G is also working to harness the power of bloggers, I like that idea. The sources report bids will be around 3 billion or so to take over the pharmaceutical division of the company. BD

Procter & Gamble is nearing a possible sale of its prescription-drug business, according to people familiar with the matter, The Wall Street Journal reported Tuesday. The sources said several parties, including Warner Chilcott and private-equity firm Cerberus Capital Management, are engaged in later-stage discussions for the unit, which could obtain bids of around $3 billion.

Taking over the division would be expected to triple Warner Chilcott's revenue and give it access to drugs that focus on a wide range of women's health concerns, the article suggested. The unnamed sources also remarked that Cerberus, which has reportedly arranged preliminary financing, proposes acquiring the division and turning it into a stand-alone company. According to the people familiar with the talks, Procter & Gamble will likely concentrate on one bidder sometime in August, and a deal could be reached by the end of summer.